Ecolab
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 13:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 8-K | 2026-11-17 | Read on SEC.gov |
| 10-Q | 2026-10-29 | Read on SEC.gov |
| 8-K | 2026-10-27 | Read on SEC.gov |
| 10-Q | 2026-08-06 | Read on SEC.gov |
| 8-K | 2026-07-28 | Read on SEC.gov |
| 8-K | 2026-05-29 | Read on SEC.gov |
| 8-K | 2026-05-11 | Read on SEC.gov |
| 10-Q | 2026-05-07 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 06:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $16.08B | Annual | 2025-12-31 | 2026-02-23 | 10-K |
| Net income | $2.08B | Annual | 2025-12-31 | 2026-02-23 | 10-K |
| Operating cash flow | $2.95B | Annual | 2025-12-31 | 2026-02-23 | 10-K |
| Total assets | $24.70B | As of | 2025-12-31 | 2026-02-23 | 10-K |
| Total liabilities | $14.89B | As of | 2025-12-31 | 2026-02-23 | 10-K |
| Stockholders’ equity | $9.77B | As of | 2025-12-31 | 2026-02-23 | 10-K |
| Cash and cash equivalents | $646.20M | As of | 2025-12-31 | 2026-02-23 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 5.12, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Global Water is the largest reported line at 52.82% of revenue, across 5 reported segments.
- Global Institutional & Specialty follows at 34.90%, so the top line still matters most but isn’t the whole story.
Revenue annual, last 8 years
Latest year +2.16% YoY
Margins
- Gross margin
- 44.46%
- Operating margin
- 17.99%
- Net margin
- 12.91%
Key ratios & quality
- Enterprise valuei
- 90.41B
- PEG ratioi
- 1.68
- Altman Z-Scorei
- 5.12
PEG uses trailing P/E against the 3-year net income growth rate (23.88%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.22B | 12.56B | 11.79B | 12.73B | 14.19B | 15.32B | 15.74B | 16.08B |
| Gross profit | 5.35B | 5.52B | 4.88B | 5.12B | 5.36B | 6.17B | 6.84B | 7.15B |
| Selling & admin expenses | 3.51B | 3.55B | 3.31B | 3.42B | 3.65B | 4.06B | 4.23B | 4.26B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.84B | 1.97B | 1.58B | 1.70B | 1.70B | 2.10B | 2.61B | 2.89B |
| Pretax profit | 1.59B | 1.73B | 1.16B | 1.41B | 1.34B | 1.76B | 2.57B | 2.55B |
| Tax | 321.20M | 288.60M | 176.60M | 270.20M | 234.50M | 362.50M | 439.30M | 454.60M |
| Net profit | 1.44B | 1.58B | -1.19B | 1.14B | 1.11B | 1.39B | 2.13B | 2.09B |
| Basic EPS | 5 | 5 | -4 | 4 | 4 | 5 | 7 | 7 |
| Diluted EPS | 4.88 | 5.33 | -4.20 | 3.91 | 3.81 | 4.79 | 7.37 | 7.28 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 4.03B | 4.17B | 4.20B | 4.07B | 4.42B | 4.69B |
| Gross profit | 1.80B | 1.87B | 1.85B | 1.77B | 1.95B | 2.07B |
| Selling & admin expenses | 1.07B | 1.08B | 1.06B | 1.10B | 1.14B | 1.18B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 734.70M | 786.40M | 786.60M | 668.40M | 804.30M | 891.90M |
| Pretax profit | 659.90M | 717.70M | 660.30M | 558.10M | 693.60M | 694.50M |
| Tax | 131.40M | 128.00M | 91.70M | 121.50M | 154.90M | 140.10M |
| Net profit | 528.50M | 589.70M | 568.60M | 436.60M | 538.70M | 554.40M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.84 | 2.05 | 1.98 | 1.52 | 1.90 | 1.95 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.68B | 4.83B | 5.12B | 4.69B | 5.49B | 5.64B | 6.03B | 5.96B |
| Cash & ST investments | 114.70M | 118.80M | 1.26B | 359.90M | 598.60M | 919.50M | 1.26B | 646.20M |
| Inventory | 1.55B | 1.08B | 1.29B | 1.49B | 1.79B | 1.50B | 1.46B | 1.49B |
| Total assets | 20.07B | 20.87B | 18.13B | 21.21B | 21.46B | 21.85B | 22.39B | 24.70B |
| Total current liabilities | 3.69B | 3.63B | 2.93B | 3.55B | 4.21B | 4.35B | 4.79B | 5.53B |
| Short-term debt | 743.60M | 502.70M | 142.90M | 526.10M | 613.40M | 756.50M | 758.00M | 1.04B |
| Long-term debt | 6.30B | 5.97B | 6.67B | 8.35B | 8.08B | 7.55B | 6.95B | 7.37B |
| Total liabilities | 12,020,900,000.00 | 12,143,300,000.00 | 11,924,500,000.00 | 13,953,300,000.00 | 14,205,700,000.00 | 13,774,400,000.00 | 13,598,600,000.00 | 14,891,800,000.00 |
| Total equity | 8.05B | 8.73B | 6.20B | 7.25B | 7.26B | 8.07B | 8.79B | 9.80B |
| Retained earnings | 8.91B | 9.99B | 8.24B | 8.81B | 9.32B | 10.08B | 11.52B | 12.83B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 7.08B | 7.11B | 5.96B | 6.04B | 11.02B | 7.10B |
| Cash & ST investments | 1.92B | 1.96B | 646.20M | 519.80M | 5.14B | 722.30M |
| Inventory | 1.57B | 1.53B | 1.49B | 1.57B | 1.64B | 1.76B |
| Total assets | 23.74B | 23.90B | 24.70B | 25.04B | 29.93B | 31.11B |
| Total current liabilities | 4.91B | 4.19B | 5.53B | 6.10B | 5.99B | 6.38B |
| Short-term debt | 844.60M | 176.50M | 1.04B | 1.74B | 1.44B | 1.45B |
| Long-term debt | 7.52B | 8.05B | 7.37B | 6.92B | 11.91B | 11.92B |
| Total liabilities | 14,385,400,000.00 | 14,143,700,000.00 | 14,891,800,000.00 | 15,008,600,000.00 | 19,842,600,000.00 | 20,653,400,000.00 |
| Total equity | 9.35B | 9.75B | 9.80B | 10.03B | 10.08B | 10.45B |
| Retained earnings | 12.08B | 12.48B | 12.83B | 13.06B | 13.39B | 13.74B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.28B | 2.42B | 1.86B | 2.06B | 1.79B | 2.41B | 2.81B | 2.95B |
| Depreciation & amortization | 730.40M | 775.30M | 812.70M | 843.10M | 938.70M | 923.60M | 935.40M | 976.40M |
| Free cash flow | 1.50B | 1.69B | 1.37B | 1.42B | 1.08B | 1.64B | 1.82B | 1.90B |
| Dividends paid | -494.80M | -552.90M | -560.80M | -566.40M | -602.80M | -617.30M | -664.30M | -753.60M |
| Stock buybacks / issuance | -562.40M | -353.70M | -146.20M | -106.60M | -518.20M | -13.70M | -986.50M | -783.80M |
| Ending cash balance | 294.00M | 186.40M | 1.26B | 359.90M | 598.60M | 919.50M | 1.26B | 646.20M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 701.80M | 791.30M | 1.09B | 445.90M | 729.50M | 763.70M |
| Depreciation & amortization | 241.70M | 242.50M | 256.10M | 263.10M | 268.90M | 287.30M |
| Free cash flow | 485.10M | 529.70M | 758.00M | 97.40M | 489.40M | 450.30M |
| Dividends paid | -188.00M | -184.40M | -189.20M | -215.90M | -208.20M | -204.60M |
| Stock buybacks / issuance | -45.50M | -175.40M | -409.20M | -344.40M | -324.90M | -2.80M |
| Ending cash balance | 1.92B | 1.96B | 646.20M | 519.80M | 5.14B | 722.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.30 | 18.68 | -16.23 | 16.88 | 15.10 | 17.96 | 25.14 | 22.40 |
| ROA %i | 7.14 | 7.61 | -6.18 | 5.75 | 5.12 | 6.34 | 9.55 | 8.82 |
| ROIC %i | 10.71 | 11.20 | -6.64 | 8.81 | 7.92 | 9.73 | 13.88 | 12.70 |
| 5-year avg ROE %i | 17.48 | 17.94 | 11.87 | 11.69 | 10.55 | 10.48 | 11.77 | 19.50 |
| EBIT margin %i | 13.92 | 14.18 | 12.44 | 12.92 | 11.25 | 13.74 | 18.50 | 17.75 |
| FCF / sales %i | 9.75 | 10.87 | 11.63 | 11.14 | 7.58 | 10.69 | 11.56 | 11.84 |
| Current ratioi | 1.27 | 1.33 | 1.75 | 1.32 | 1.30 | 1.30 | 1.26 | 1.08 |
| Quick ratioi | 0.79 | 0.72 | 1.26 | 0.84 | 0.83 | 0.91 | 0.89 | 0.77 |
| Debt / assetsi | 35.10 | 32.69 | 39.24 | 43.18 | 42.05 | 39.98 | 37.00 | 36.43 |
| LT debt / equityi | 78.74 | 72.76 | 113.03 | 119.46 | 116.27 | 99.16 | 85.92 | 81.49 |
| Interest coveragei | 8.61 | 9.82 | 4.81 | 7.13 | 6.33 | 6.03 | 8.56 | 9.32 |
| Revenue CAGR (3Y) %i | -3.37 | -1.52 | -5.19 | 1.37 | 4.14 | 9.12 | 7.33 | 4.26 |
| Net income CAGR (3Y) %i | 12.56 | 8.25 | -- | -7.53 | -11.20 | -- | 23.19 | 23.88 |
| FCF CAGR (3Y) %i | 8.16 | 12.61 | 3.89 | -1.81 | -13.97 | 6.08 | 8.64 | 20.97 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 24.26 | 21.73 | 22.40 | 22.31 | 21.85 | 20.68 |
| ROA %i | 9.45 | 8.63 | 8.82 | 8.88 | 7.89 | 7.57 |
| ROIC %i | 13.49 | 12.33 | 12.70 | 12.68 | 11.01 | 10.94 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 19.12 | 17.14 | 17.75 | 17.67 | 17.53 | 17.22 |
| FCF / sales %i | 10.01 | 9.78 | 11.84 | 11.37 | 11.13 | 10.33 |
| Current ratioi | 1.44 | 1.70 | 1.08 | 0.99 | 1.84 | 1.11 |
| Quick ratioi | 1.05 | 1.26 | 0.77 | 0.68 | 1.50 | 0.77 |
| Debt / assetsi | 37.78 | 36.95 | 36.43 | 37.01 | 46.51 | 44.81 |
| LT debt / equityi | 87.15 | 89.04 | 81.49 | 75.23 | 124.13 | 119.85 |
| Interest coveragei | 9.56 | 9.01 | 9.32 | 9.35 | 9.14 | 7.78 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.
Ecolab discussion 0 comments